Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
US Army
Healthtrust
Covington
Queensland Health
US Department of Justice
Harvard Business School
Fuji

Generated: November 12, 2018

DrugPatentWatch Database Preview

Ioflupane i-123 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ioflupane i-123 and what is the scope of ioflupane i-123 patent protection?

Ioflupane i-123 is the generic ingredient in one branded drug marketed by Ge Hlthcare Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for ioflupane i-123
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 4
Clinical Trials: 1
Patent Applications: 1
DailyMed Link:ioflupane i-123 at DailyMed
Pharmacology for ioflupane i-123
Synonyms for ioflupane i-123
123I-beta-CIT-FP)
123I-FP-CIT
123I-Ioflupane
155798-07-5
3MM99T8R5Q
AC1MJ6LK
CHEBI:68855
DaTSCAN
DB08824
GTPL7653
HE314659
Iodine ioflupane (123i)
Ioflupane
ioflupane ((123)I)
Ioflupane ((sup 123)I)
IOFLUPANE (123 I)
ioflupane (123I)
Ioflupane (123I) [INN]
IOFLUPANE I 123
Ioflupane I 123 [USAN:INN:BAN]
Ioflupane I 123 [USAN]
Ioflupane I-123 and iodine
ioflupane I(123)
ioflupano (123I)
ioflupanum (123I)
methyl (1R,2S,3S,5S)-8-(3-fluoropropyl)-3-[4-((123)I)iodophenyl]-8-azabicyclo[3.2.1]octane-2-carboxylate
methyl (1S,3S,4S,5R)-8-(3-fluoropropyl)-3-(4-iodanylphenyl)-8-azabicyclo[3.2.1]octane-4-carboxylate
Methyl 8-(3-fluoropropyl)-3beta-(p-iodo-(sup 123)I-phenyl)-1alphaH,5alphaH-nortropane-2beta-carboxylate
Methyl 8-(3-fluoropropyl)-3beta-(p-iodo-I(sup 123)-phenyl)-1alphaH, 5alphaH-nortropane-2beta-carboxylate
SCHEMBL16472968
UNII-3MM99T8R5Q
V-09AB03
V09AB03

US Patents and Regulatory Information for ioflupane i-123

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Hlthcare Inc DATSCAN ioflupane i-123 SOLUTION;INTRAVENOUS 022454-001 Jan 14, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
US Army
Healthtrust
Covington
Queensland Health
US Department of Justice
Harvard Business School
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.